Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. The standard site chrome remains visible, but the actual content is inaccessible, signaling a access restriction rather than a change to the study information.SummaryDifference19%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6. This indicates a minor platform/update change and does not modify study content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, replacing the previous version tag as part of a minor maintenance update to the page’s documentation/versioning.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3 on the page. This indicates a minor update to the page's metadata or formatting rather than any change to the study details.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the page. This update does not modify any study details or how the page is used.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page revision label has been updated from v3.6.0 to v3.6.2. This reflects a recent update to the page's revision metadata and does not modify the visible study content.SummaryDifference0.1%

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.